Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology 1993: Vol 26 Index

4 Pages·1993·1.6 MB·English

Radiotherapy and Oncology, 26 (1993) 289-291
© 1993 Elsevier Scientific Publishers Ireland Ltd. All rights reserved. 0167-8140/93/$06.00 289
AUTHOR INDEX
Arriagada, R., see Haie-Meder, C., 111 El-Gayed, A. A. H., Bel, A., Vijlbrief, R., Bartelink, H. and Leb-
Ashley, S., see Rajan, B., 1 esque, J. V., Time trend of patient setup deviations during pelvic
Aten, J. A., see Bakker, P. J. M., 69 irradiation using electronic portal imaging, 162
Bakker, P. J. M., Tukker, L. J., Stap, J., Veenhof, C. H. N. and Aten, Feins, R., see McDonald, S., 212
J. A., Micronuclei expression in tumours as a test for radiation Feldmann, H. J., Molls, M., Heinemann, H.-G., Romanowski, R..,
sensitivity, 69 Stuschke, M. and Sack, H., Thermoradiotherapy in locally ad-
Bartelink, H., see El-Gayed, A. A. H., 162 vanced deep seated tumours — thermal parameters and treatment
BauBmann, E., see Hdckel, M., 45 results, 38
Beck, H., see Seegenschmiedt, M. H., 271 Finkelstein, J. N., see McDonald, S., 212
Bel, A., see El-Gayed, A. A.H , 162 Flentje, M., see Frank, C., 264
Bellotti, J. E., Kagan, A. R., Wollin, M. and Olch, A., Application Fourquet, A., Teillaud, J.-L., Lando, D. and Fridman, W.-H., Effects
of the ICRU Report 38 reference volume concept to the radio- of low dose total body irradiation (LDTBI) and recombinant
therapeutic management of recurrent endometrial and cervical human interleukin-2 in mice, 219
carcinoma, 254 Fowler, J. F., see Gasinska, A., 244
Bey, P., see Chassagne, D., 195 Frank, C., Weber, K. J., Fritz, P. and Flentje, M., Increased dose-
Bloom, H. J. G., see Rajan, B., 1 rate effect in V79-multicellular aggregates (spheroids). Relation to
Bol, A., see Vynckier, S., 275 initial DNA lesions and repair, 264
Bonet, A., see Macia, M., 146 Freshwater, D. B., see Iwamoto, K. S., 76
Bos, J., see van *t Riet, A., 82 Fridman, W.-H., see Fourquet, A., 219
Bostrém, P., see Joensuu, H., 33 Fritz, P., see Frank, C., 264
Brada, M., see Rajan, B., 1
Brown, J. M., see Spiegel, J. F., 79 Gaeta, M., see Russie, E. G., 172
Brun, A., see Ceberg, C. P., 139 Gasinska, A., Dubray, B., Hill, S. A., Denekamp, J., Thames, H. D.
and Fowler, J. F., Early and late injuries in mouse rectum after
Ceberg, C. P., Salford, L.G., Brun, A., Hemler, R. J. B. and Pers- fractionated X-ray and neutron irradiation, 244
son, B. R. R., Neutron capture imaging of '°B in tissue speci- Gerbaulet, A., see Chassagne, D., 195
mens, 139 Goldmann, A. R., see Seegenschmiedt, M. H., 271
Chang, A. Y. C., see McDonald, S., 212 Gorman, C., see Rajan, B., 1
Chassagne, D., Sismondi, P., Horiot, J. C., Sinistrero, G., Bey, P., Gregory, P. K., see McDonald, S., 212
Zola, P., Pernot, M., Gerbaulet, A., Kunkler, I. and Michel, G.., Grimard, L., see Simon, J. M., 19
A glossary for reporting complications of treatment in gyneco- Grossberg, S., see McDonald, S., 212
logical cancers, 195 Gueulette, J., see Lambin, P., 73
Chomiczewski, K., Hendry, J. H. and Potten, C. S., Accelerated
repopulation of intestine post-irradiation following intraluminal Haie-Meder, C., Pellae-Cosset, B., Laplanche, A., Lagrange, J. L.,
injection of a mucosal cell suspension or its supernatant, 64 Tuchais, C., Nogues, C. and Arriagada, R., Results of a random-
Chui, C. S., see Ling, C. C., 11 ized clinical trial comparing two radiation schedules in the pal-
Coster, B., see Lambin, P., 73 liative treatment of brain metastases, 111
Crook, J. M., see Simon, J. M., 19 Hedy Mameghan, , see Kron, T., 151
Heinemann, H.-G., see Feldmann, H. J., 38
D’Aquino, A., see Russie, E. G., 172 Hemler, R. J. B., see Ceberg, C. P., 139
De Blas, R., see Macia, M., 146 Hendry, J. H., see Chomiczewski, K., 64
Delia, P., see Russie, E. G., 172 Hendry, J. H., see Jen, Y.-M., 117
Denekamp, J., see Gasinska, A., 244 Hill, S. A., see Gasinska, A., 244
Derreumaux, S., see Vynckier, S., 275 Hill, R. P., see Newcomb, C. H., 51
Doherty, M. A., Rodger, A., Langlands, A. O. and Kerr, G. R., Mul- Hill, R. P., see Shun Wong, C., 132
tiple primary tumours in patients treated with radiotherapy for Hockel, M., Knoop, C., Schlenger, K., Vorndran, B., BauBmann, E.,
breast cancer, 125 Mitze, M., Knapstein, P. G. and Vaupel, P., Intratumoral pO,
Dubray, B., see Gasinska, A., 244 predicts survival in advanced cancer of the uterine cervix, 45
Dunscombe, P., Loose, S. and Leszczynski, K., Sizes and sources Hoekstra, C. J. M., see van ’t Riet, A., 82
of field placement error in routine irradiation for prostate cancer, Hohmann, D., see Seegenschmiedt, M. H., 271
174 Horiot, J. C., see Chassagne, D., 195
Durosinmi-Etti, F. A. and Mouelle-Sone, A., A regional training pro- Horwich, A., see Rajan, B., 1
gramme for radiotherapists and allied professionals for the West Hosoi, Y. and Sakamoto, K., Suppressive effect of low dose total
African health community, 260
290
body irradiation on lung metastasis: dose dependency and effec- Mouelle-Sone, A., see Durosinmi-Etti, F. A., 260
tive period, 177 Murray, A., see Kron, T., 151
M’Vondo, J. C., see Lambin, P., 73
Ingram, M., see Iwamoto, K. S., 76
Iwamoto, K. S., Norman, A., Freshwater, D. B., Ingram, M. and Newcomb, C. H., Van Dyk, J. and Hill, R. P., Evaluation of isoeffect
Skillen, R. G., Diagnosis and treatment of spontaneous canine formulae for predicting radiation-induced lung damage, 51
brain tumors with a CT scanner, 76 Nogues, C., see Haie-Meder, C., 111
Norman, A., see Iwamoto, K. S., 76
Jackson, A., see Yorke, E. D., 226
Jen, Y.-M. and Hendry, J. H., Dose-fractionation sensitivity of mouse Olch, A., see Bellotti, J. E., 254
kidney clonogens measured using different interfraction intervals
and postirradiation assay times, 117 Pellae-Cosset, B., see Haie-Meder, C., 111
Joensuu, H., Bostrém, P. and Makkonen, T., Pilocarpine and car- Penney, D. P., see McDonald, S., 212
bacholine in treatment of radiation-induced xerostomia, 33 Pergolizzi, S., see Russie, E. G., 172
Johansson, H., see Rutqvist, L. E., 104 Pernot, M., see Chassagne, D., 195
Jose, C. C., see Rajan, B., 1 Persson, B. R. R., see Ceberg, C. P., 139
Pettersson, D., see Rutqvist, L. E., 104
Kagan, A. R., see Bellotti, J. E., 254 Piedbois, P., see Simon, J. M., 19
Kerr, G. R., see Doherty, M. A., 125 Pierquin, B., see Simon, J. M., 19
Knapstein, P. G., see Hickel, M., 45 Pohar, S., see Simon, J. M., 19
Knoop, C., see Héckel, M., 45 Poon, J. K., see Shun Wong, C., 132
Kojs, Z., see Reinfuss, M., 26 Potten, C. S., see Chomiczewski, K., 64
Kron, T., Schneider, M., Murray, A. and Hedy Mameghan, , Clin-
ical thermoluminescence dosimetry: how do expectations and Rajan, B., Ashley, S., Gorman, C., Jose, C. C., Horwich, A., Bloom,
results compare?*, 151 H. J. G., Marsh, H. and Brada, M., Craniopharyngioma — long-
Kunkler, I., see Chassagne, D., 195 term results following limited surgery and radiotherapy, 1
Kutcher, G. J., see Yorke, E. D., 226 Reinfuss, M., Kojs, Z. and Skolyszewski, J., External beam radio-
therapy in the management of ovarian carcinoma, 26
Lagrange, J. L., see Haie-Meder, C., 111 Richard, F., see Vynckier, S., 275
Lambin, P., Scalliet, P., Coster, B., M’Vondo, J. C., Vynckier, S., Rodger, A., see Doherty, M. A., 125
Gueulette, J. and Wambersie, A., Influence of cisplatinum on Romanowski, R., see Feldmann, H. J., 38
intestinal tolerance to photon and neutron irradiation in mice, 73 Rubin, P., see McDonald, S., 212
Lando, D., see Fourquet, A., 219 Rubio, A. M., see Macia, M., 146
Langlands, A. O., see Doherty, M. A., 125 Rumore,A,. , see Sinistrero, G., 203
Laplanche, A., see Haie-Meder, C., 111 Russie, E. G., Pergolizzi, S., Gaeta, M., Mesiti, M., D’Aquino, A.
Lebesque, J. V., see El-Gayed, A. A. H., 162 and Delia, P., Palliative-radiotherapy in lumbosacral carcinoma-
Le Bourgeois, J. P., see Simon, J. M., 19 tous neuropathy, 172
Le Péchoux, C., see Simon, J. M., 19 Rutqvist, L. E., Pettersson, D. and Johansson, H., Adjuvant radia-
Leszczynski, K., see Dunscombe, P., 174 tion therapy versus surgery alone in operable breast cancer: long-
Ling, C. C. and Chui, C. S., Stereotactic treatment of brain tumors term follow-up of a randomized clinical trial, 104
with radioactive implants or external photon beams: radiobio-
physical aspects, 11 Sack, H., see Feldmann, H. J., 38
Ling, C. C., see Yorke, E. D., 226 Sakamoto, K., see Hosoi, Y., 177
Loose, S., see Dunscombe, P., 174 Salford, L. G., see Ceberg, C. P., 139
Sauer, R., see Seegenschmiedt, M. H., 271
Macia, M., Rubio, A. M., De Blas, R., Monfa, C. and Bonet, A., Scalliet, P., see Lambin, P., 73
Treatment charts in radiation therapy. An analysis of European Schlenger, K., see Hickel, M., 45
treatment records, 146 Schneider, M., see Kron, T., 151
Mak, A. C. A., see van ’t Riet, A., 82 Seegenschmiedt, M.H., Goldmann, A. R., W6lfel, R., Hohmann,
Makkonen, T., see Joensuu, H., 33 D., Beck, H. and Sauer, R., Prevention of heterotopic ossifica-
Marsh, H., see Rajan, B., 1 tion (HO) after total hip replacement: randomized high versus
Mason, K. A., see Withers, H. R., 238 low dose radiotherapy, 271
Mazeron, J. J., see Simon, J. M., 19 Shun Wong, C., Poon, J. K. and Hill, R. P., Re-irradiation tolerance
McDonald, S., Rubin, P., Chang, A. Y. C., Penney, D. P., Finkel- in the rat spinal cord: influence of level of initial damage, 132
stein, J. N., Grossberg, S., Feins, R. and Gregory, P. K., Pulmo- Simon, J. M., Mazeron, J. J., Pohar, S., Le Péchoux, C., Crook,
nary changes induced by combined mouse f-interferon J.M., Grimard, L., Piedbois, P., Le Bourgeois, J. P. and Pier-
(rMuIFN-f) and irradiation in normal mice — toxic versus pro- quin, B., Effect of intersource spacing on local control and com-
tective effects, 212 plications in brachytherapy of mobile tongue and floor of mouth,
Mesiti, M., see Russie, E. G., 172 19
Michel, G., see Chassagne, D., 195 Sinistrero, G., see Chassagne, D., 195
Michel, C., see Vynckier, S., 275 Sinistrero, G., Sismondi, P., Rumore, A. and Zola, P., Analysis of
Mitze, M., see Hickel, M., 45 complications of cervix carcinoma treated by radiotherapy using
Molls, M., see Feldmann, H. J., 38 the Franco-Italian glossary, 203
Monfa, C., see Macia, M., 146 Sismondi, P., see Chassagne, D., 195
Sismondi, P., see Sinistrero, G., 203 Veenhof, C. H. N., see Bakker, P. J. M., 69
Skillen, R. G., see Iwamoto, K. S., 76 Vijlbrief, R., see El-Gayed, A. A. H., 162
Skolyszewski, J., see Reinfuss, M., 26 Vorndran, B., see Hickel, M., 45
Spear, M. A., see Spiegel, J. F., 79 Vynckier, S., Derreumaux, S., Richard, F., Bol, A., Michel, C. and
Spiegel, J. F., Spear, M. A. and Brown, J. M., Toxicology of daily Wambersie, A., Is it possible to verify directly a proton-treatment
administration to mice of the radiation potentiator SR 4233 plan using positron emission tomography?, 275
(WIN 59075), 79 Vynckier, S., see Lambin, P., 73
Stap, J., see Bakker, P. J. M., 69
Stenfert Kroese, M. C., see van ’t Riet, A., 82 Wambersie, A., see Lambin, P., 73
Stuschke, M., see Feldmann, H. J., 38 Wambersie, A., see Vynckier, S., 275
Weber, K. J., see Frank, C., 264
Taylor, J. M. G., see Withers, H. R., 238 Withers, H. R., Mason, K. A. and Taylor, J. M. G., The number of
Teillaud, J.-L., see Fourquet, A., 219 clonogenic cells in a mouse jejunal crypt, 238
Te Loo, H.J., see van ’t Riet, A., 82 Wolfel, R., see Seegenschmiedt, M. H., 271
Thames, H. D., see Gasinska, A., 244 Wollin, M., see Bellotti, J. E., 262
Tuchais, C., see Haie-Meder, C., 111
Tukker, L. J., see Bakker, P. J. M., 69 Yorke, E. D., Kutcher, G. J., Jackson, A. and Ling, C. C., Proba-
bility of radiation-induced complications in normal tissues with
Van Dyk, J., see Newcomb, C. H., 51 parallel architecture under conditions of uniform whole or partial
Van ’t Riet, A., te Loo, H. J., Mak, A.C. A., Veen, R. E., Ypma, organ irradiation, 226
A. F. G. V. M., Bos, J., Hoekstra, C. J. M. and Stenfert Kroese, Ypma, A. F. G. V. M., see van ’t Riet, A., 82
M. C., Evaluation of brachytherapy implants using the “natural”
volume—dose histogram, 82 Zola, P., see Chassagne, D., 195
Vaupel, P., see Hickel, M., 45 Zola, P., see Sinistrero, G., 203
Veen, R. E., see van ’t Riet, A., 82
Radiotherapy and Oncology, 26 (1993) 292
© 1993 Elsevier Scientific Publishers Ireland Ltd. All rights reserved. 0167-8140/93/$06.00
SUBJECT INDEX
Anisotonicity, 264 Intestinal tolerance, 73 Prostate carcinoma, 162
Intestine, 64 Protontherapy, 275
Bio-distribution, 139 In vivo dosimetry, 151
Biological model, 226 Ionizing radiation, 69 Quality assurance, 146, 195
Bioreductive agent, 79 Iridium-192, 19, 82
Biadder, 82 Irradiation, 212 Radiation-induced complications, 226
Blood flow, 38 Isoeffect formulae, 51 Radiation injury, 244
BNCT, 139 Radiation therapy, 104, 254
Boron imaging, 139 Jejunal mucosa, 238 Radiobiology, 11
Brachytherapy, 254 Radiosurgery, 11
Brain metastasis, 111 Kidney clonogens, 117 Radiotherapy, 1, 19, 33, 111, 125, 162, 172,
Brain tumor, 76 93, 203, 238
Breast cancer, 104, 125 Limited surgery, 1 Radiotherapy chart, 146
Linear-quadratic model, 244 Radiotherapy quality control, 174
Cancer of the cervix, 203 Local control, 19 Radiotherapy resources, 260
Cancer of the uterine cervix, 45 Long-term results, 104 Radiotherapy treatment records, 146
Carbacholine, 33 Long-term survival, 1 Radiotherapy treatment verification, 151
Carcinoma of cervix, 93 LQ model: Neutrons, 117 Randomized trial, 104, 111
Carcinomatous neuropathy, 172 Lumbosacral plexus, 172 Rat spinal cord, 132
Cervix, 195 Lung damage, 51 RBE, 242
Cisplatinum, 73 Recovery, 117
CNS radiation tolerance, 132 Metastasis, 177 Rectal carcinoma, 162
Colony forming cells, 117 Microclusters/colonies, 64 Reporting, 195
Computerized tomography, 76 Micronucleus assay, 69 Retreatment, 132
Craniopharyngioma, 1 Mobile tongue, 19 Ro 03-8799 (pimonidazole), 93
Cytotoxicity, 219 Mouse rectum, 244
Mucosal cells, 64 Scoring, 195
Deep-seated tumour, 38 Multifraction, 79 Self-absorption, 139
Definition, 195 Multiple primary tumour, 125 Spheroid, 264
Dose fractionation, 238 Splenocyte, 219
Dose-rate, 264 Neck cancer, 33 Squamous cell carcinoma, 19
Dose-survival curves, 238 Necrosis, 19 SR 4233, 79
Dose-volume analysis, 254 Neutron, 73, 238, 244 Stem cells, 238
Double-strand break, 264 Surgery, 195
Observed response, 38
Endometrium, 195 Observed toxicity, 38 Thermoluminescence dosimetry, 151
External beam radiotherapy, 26 Oral cavity, 82 Thermoradiotherapy, 38
Organ irradiation, 226 Time factor, 51
Fibrosis, 212 Ovarian carcinoma, 26 TLD, 151
Floor of mouth, 19 Total body irradiation, 177, 219
Total hip arthroplasty, 271
Glioma, 139 Patient setup error, 162 Toxicology, 79
Gynecologic oncology, 254 Pelvic irradiation, 162 Track-films, 139
Personnel training, 260 Treatment, 195
Head cancer, 33 Photon, 73 Tumor hypoxia, 45
Heterotopic bone formation, 271 Pilocarpine, 33 Tumor oxygenation, 45
Hip abnormality, 271 Pneumonitis, 212 Tumour, 69
Humoral factor, 64 Portal imaging, 162
Hyperthermia, 38 Portal verification, 174 Vascular leak syndrome, 219
Positron emission tomography (PET), 275 Vision, |
Interferon-B, 212 Postoperative hip irradiation, 27]
Interleukin-2, 219 Predictive assay, 45 West Africa, 260
Intersource spacing, 19 Predictive testing, 69
Interstitial, 82 Prognostic indicator, 45 Xerostomia, 33
Interstitial brain implant, 11 Prostate cancer, 174 X-ray, 244